EU-funded projects

The main issue addressed by the project is that the steps required for the application of radioligand therapies must be actively monitored and performed on time to ensure that the patient receives therapy promptly. This ensures the best possible treatment outcomes and helps avoid losses due to the untimely use of drugs intended for therapy: radiopharmaceuticals.

The project aims to develop a digital Integrated Theranostic Oncology Platform (ITOP) that analyses the patient's clinical information, initial and follow-up examination data, and the course of treatment.

The platform would reduce the administrative workload of doctors and other medical staff when planning and monitoring radioligand therapies, and ensure the efficient use of healthcare infrastructure.

The total value of the project is EUR 303,290. The project is co-financed by the European Union: EUR 200,000 is allocated from EU funds. The project activities run from 25 June 2025 to 25 October 2026.